Editorial

  • HOME
  • ARTICLE CATEGORY
  • Editorial
Editorial
Association of nonalcoholic fatty liver disease with incident dementia later in life among elderly adults
Byoung Seok Ye
Clin Mol Hepatol. 2022;28(3):481-482.   Published online May 16, 2022
View: 839   Download: 41
A crystal ball to forecast treatment responsiveness in nonalcoholic fatty liver disease
Seonghwan Hwang, Won Kim
Clin Mol Hepatol. 2022;28(3):478-480.   Published online June 16, 2022
View: 866   Download: 39
1687
Does nonalcoholic fatty liver disease predispose patients to carotid arteriosclerosis and ischemic stroke?
Qian Jin, Rui-Xu Yang, Jian-Gao Fan
Clin Mol Hepatol. 2022;28(3):473-477.   Published online June 22, 2022
View: 880   Download: 51
Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles
Hung-Yao Lin, Tai-Chung Tseng
Clin Mol Hepatol. 2022;28(2):181-182.   Published online February 21, 2022
View: 1309   Download: 73
1628
Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis
Takumi Kawaguchi, Takuji Torimura
Clin Mol Hepatol. 2022;28(2):177-180.   Published online August 26, 2021
View: 1914   Download: 100
Surgical resection versus ablation for early hepatocellular carcinoma: The debate is still open
Bo Hyun Kim
Clin Mol Hepatol. 2022;28(2):174-176.   Published online January 26, 2022
View: 1280   Download: 65
Non-alcoholic fatty liver disease in pregnancy, paving the way for adverse pregnancy outcome risk assessment
Ja-Young Kwon
Clin Mol Hepatol. 2022;28(1):50-51.   Published online November 22, 2021
View: 1596   Download: 67
Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?
Seung Mi Lee, Won Kim
Clin Mol Hepatol. 2022;28(1):47-49.   Published online November 30, 2021
View: 1625   Download: 70
Can hepatocellular carcinoma recurrence be prevented after liver transplantation?
Jong Man Kim
Clin Mol Hepatol. 2021;27(4):562-563.   Published online September 23, 2021
View: 1711   Download: 92  Citation: 1
Risk of hepatocellular carcinoma in untreated patients with chronic hepatitis B: Independent of HBeAg status?
Ho Soo Chun, Minjong Lee
Clin Mol Hepatol. 2021;27(3):448-450.   Published online June 23, 2021
View: 1843   Download: 95
An analysis of polygenic risk scores for non-alcoholic fatty liver disease
Dae Won Jun
Clin Mol Hepatol. 2021;27(3):446-447.   Published online May 21, 2021
View: 2154   Download: 111
Another oral antiviral treatment, but still far away from hepatitis B virus cure
Tai-Chung Tseng
Clin Mol Hepatol. 2021;27(2):281-282.   Published online March 10, 2021
View: 1823   Download: 91  Citations: 2
Biopsy or cytology for diagnosing hepatic focal lesions?
Haeryoung Kim
Clin Mol Hepatol. 2021;27(2):278-280.   Published online March 4, 2021
View: 1702   Download: 57
Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Vincent Wai-Sun Wong
Clin Mol Hepatol. 2021;27(2):273-277.   Published online February 1, 2021
View: 2167   Download: 105  Citations: 2
A need for patient-centered care in managing patients with liver cirrhosis
Eileen L. Yoon
Clin Mol Hepatol. 2021;27(2):270-272.   Published online January 27, 2021
View: 1699   Download: 78
Old hepatitis B virus never dies: It just hides itself within the host genome
Jeong-Hoon Lee
Clin Mol Hepatol. 2021;27(1):107-109.   Published online December 23, 2020
View: 2066   Download: 92  Citations: 2
Exploring the mythical abscopal effect: Radiation and programmed cell death protein 1 (PD-1) blockade for hepatocellular carcinoma
Jun Won Kim, Ik Jae Lee
Clin Mol Hepatol. 2021;27(1):103-106.   Published online December 14, 2020
View: 1904   Download: 83
Elimination of hepatitis C: What would be the practical approach?
Hyung Joon Yim
Clin Mol Hepatol. 2021;27(1):97-99.   Published online December 3, 2020
View: 2685   Download: 91  Citations: 2
Alcohol-related cirrhosis: The most challenging etiology of cirrhosis is more burdensome than ever
Marta Tonon, Salvatore Piano
Clin Mol Hepatol. 2021;27(1):94-96.   Published online December 3, 2020
View: 2183   Download: 103  Citations: 2
1590
Metabolic disease as a risk of hepatocellular carcinoma
Naoshi Nishida
Clin Mol Hepatol. 2021;27(1):87-90.   Published online December 3, 2020
View: 2534   Download: 88  Citations: 7
1588
Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try
Tian-Yi Ren, Xiao-Yan Li, Jian-Gao Fan
Clin Mol Hepatol. 2021;27(1):83-86.   Published online December 3, 2020
View: 2598   Download: 121
Drug-drug interactions with direct-acting antivirals — less is more
Grace Lai-Hung Wong
Clin Mol Hepatol. 2021;27(1):81-82.   Published online December 3, 2020
View: 2010   Download: 85  Citation: 1
Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma
Jaewhan Song
Clin Mol Hepatol. 2020;26(4):484-486.   Published online October 1, 2020
View: 3617   Download: 95  Citations: 4
Long-term prognosis and management of hepatocellular carcinoma after curative treatment
Naoshi Nishida
Clin Mol Hepatol. 2020;26(4):480-483.   Published online September 21, 2020
View: 3065   Download: 85  Citations: 5

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 465
TOTAL : 975413
Close layer